Closed Loop Medicine

Activities: Training & Education Regulatory

Trending Articles

  1. At CPHI Milan, TekniPlex Healthcare to Highlight New Solutions for Single-use Bioprocessing, Cell & Gene Therapies Company also will provide live demos of next-generation automatic filler-sealer for single-dose plastic vials, and showcase sustainability-minded blister packaging, as well as...
  2. Meet Gaelic Laboratories at CPHI Milan Visit us in Hall 5 to learn more about our advanced Beta-Lactam manufacturing facilities, and our newly-equipped laboratories offering rapid and cost-effective release testing
  3. PolTREG's Treg cell therapy exhibits long-term clinical remission in type 1 diabetes patients The clinical-stage biotech's lead candidate, PTG-007, has demonstrated its ability to induce clinical remission in T1D patients for up to 12 years
  4. APL and CurifyLabs join forces to personalise medicinal administration with 3D printing The companies will manufacture personalised medicines with specific dosages and dosage form characteristics for frail and young patients
  5. SGS to showcase integrated drug development solutions at CPhI, Milan Explore SGS’s comprehensive services from analytical testing to clinical research at booth 5D82

Upcoming event

Boston Biotech Week

23-26 September, 2024 | Convention and exhibition | Boston, US See all

Related Content

Digital

Closed Loop Medicine appoints Paul Johnson as Non-Executive Director

Paul will work with the company to drive forward its commercialisation strategy for its portfolio of precision care solutions
Research & Development

Closed Loop Medicine & Pharmanovia's OptiZest study for precision hypertension therapeutic commences

The study will investigate the efficacy of at-home, personalised dose management with Zestril for the treatment of hypertension
Research & Development

Teva UK and Closed Loop Medicine partner to advance personalised medicine development

SaMD platform aims to advance personalised medicine development, improve drug efficacy and patient outcomes with specific chronic conditions
Regulatory

First-line anti-hypertensive drug and software partnership

Hypertension is the leading preventable cause of morbidity and premature death worldwide, impacting over 1 in 4 men and 1 in 5 women, and costing the NHS alone over £2.1 billion/year
Subscribe now